文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

Tubastatin A预防出血诱导的内皮屏障功能障碍

Tubastatin A prevents hemorrhage-induced endothelial barrier dysfunction.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论在大鼠40%失血模型中,Tubastatin A减少急性肺损伤,并在体外减轻缺氧诱导的内皮高通透性、HIF-1α表达和糖萼脱落。

研究探讨组蛋白去乙酰化酶6抑制剂Tubastatin A(TubA)能否预防创伤相关内皮屏障功能障碍。Wistar-Kyoto大鼠经历40%失血后接受TubA或溶剂对照,失血后6小时取组织行组织学评估急性肺损伤。体外将人脐静脉内皮细胞置于无糖培养基中,加入或不加TubA,在缺氧舱(5% CO2、95% N2)中培养20-48小时检测乙酰化微管蛋白、HIF-1α、可溶性ICAM-1及单层通透性。结果显示TubA组大鼠急性肺损伤较溶剂对照显著减轻;体外TubA显著减轻缺氧诱导的高通透性、HIF-1α表达和糖萼脱落。作者认为TubA可能减轻出血性休克相关的微血管高通透性。

要点

  • 在大鼠40%失血模型中,TubA组失血后6小时组织学评估的急性肺损伤较溶剂对照组显著减轻。
  • 体外缺氧(5% CO2、95% N2,20-48小时)条件下,TubA显著减轻人脐静脉内皮细胞单层的高通透性。
  • 体外TubA显著减轻缺氧诱导的HIF-1α表达和糖萼脱落。
  • 作者认为TubA可能减轻出血性休克相关的微血管高通透性。

适用人群与场景

  • Wistar-Kyoto大鼠经历40%失血,用于在体评估急性肺损伤。
  • 体外使用人脐静脉内皮细胞(HUVEC),在无糖DMEM(0.5%胎牛血清)中于缺氧舱(5% CO2、95% N2)培养20-48小时。

研究设计与关键结果

  • 研究类型:动物实验(大鼠40%失血模型)联合体外细胞实验。
  • 在体:大鼠失血后接受TubA或溶剂对照,失血后6小时取组织行组织学评估,TubA组急性肺损伤较溶剂对照组显著减轻。
  • 体外:HUVEC在无糖培养基中缺氧(5% CO2、95% N2)20-48小时,TubA显著减轻缺氧诱导的高通透性(transwell法,FITC标记白蛋白)。
  • 体外:TubA显著减轻缺氧诱导的HIF-1α表达(Western blot)和糖萼脱落(可溶性ICAM-1 ELISA)。
  • 作者结论:TubA预防大鼠出血诱导的急性肺损伤,并在体外预防缺氧诱导的内皮屏障功能障碍;这些结果提示TubA可能减轻出血性休克相关的微血管高通透性。

证据类型、等级与局限

  • 证据类型:动物实验与体外细胞实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐;作者认为TubA可能减轻出血性休克相关的微血管高通透性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Microvascular hyperpermeability resulting from endothelial barrier dysfunction (EBD) is associated with worse clinical outcomes in trauma-induced hemorrhagic shock. We have previously shown that treatment with Tubastatin A (TubA), a histone deacetylase 6 inhibitor, improves outcomes in animal models of shock. In this study, we investigate whether TubA treatment may prevent trauma-related EBD.

METHODS: Wistar-Kyoto rats subjected to 40% hemorrhage were treated with TubA or vehicle control. Acute lung injury (ALI) was assessed histologically from tissues harvested 6 hours posthemorrhage. In vitro, human umbilical vein endothelial cells (HUVECs) were cultured in EGM BulletKit medium. Medium was exchanged for glucose-free Dulbecco's Modified Eagle Medium (0.5% fetal bovine serum) with or without TubA, and cells were placed in an anoxic chamber (5% CO2, 95% N2, 20-48 hours). Expression of acetylated tubulin and hypoxia-inducible factor 1α was measured by Western blot. Soluble Intercellular Adhesion Molecule-1 concentration within the medium, a marker of endothelial integrity, was determined using enzyme-linked immunosorbent assay. Monolayers were assessed for permeability via transwell assays using fluorescein isothiocyanate-labeled albumin.

RESULTS: Rats treated with TubA had significantly reduced ALI relative to vehicle control. In vitro, TubA significantly attenuated anoxia-induced hyperpermeability, hypoxia-inducible factor 1α expression, and glycocalyx shedding.

CONCLUSIONS: Our findings demonstrate that TubA prevents hemorrhage-induced ALI in rats. Additionally, we have shown that TubA prevents anoxia-induced EBD in vitro. Taken together, these results suggest that TubA could attenuate microvascular hyperpermeability related to hemorrhagic shock.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Bruhn PJ, Nikolian VC, Halaweish I, et al. Tubastatin A prevents hemorrhage-induced endothelial barrier dysfunction. J Trauma Acute Care Surg. 2018. PMID: 29194316. doi:10.1097/TA.0000000000001753

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。